Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_assertion description "[Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_assertion evidence source_evidence_literature NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_assertion SIO_000772 16682955 NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_assertion wasDerivedFrom befree-2016 NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_assertion wasGeneratedBy ECO_0000203 NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.
- befree-2016 importedOn "2016-02-19" NP548763.RAKqTb2GMl--1xHx_HnM-Llsv2NEhztAXzl5kC6de8FcE130_provenance.